Skip to content

AuraGain 408400000Recalls & reported problems

Ambu A/S · Ambu AuraGain Size 4 · Class 1

Adverse event reports
4
Deaths reported
0
Injuries reported
4
Recalls naming it
0

Summary

The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 05707480129577), received between Jul 10, 2025 and Jun 24, 2026 — classified as 4 injuries.

The most frequently reported specific device problem is “Device Appears to Trigger Rejection” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 2 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 2 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Device Appears to Trigger Rejection2
  • Inadequacy of Device Shape and/or Size2

Patient problems

  • Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available2
  • Hematoma2
  • Hemorrhage/Blood Loss/Bleeding2
  • Hyporesponsive to stimuli2
  • Nerve Damage2

Recent adverse event reports

The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.

  • InjuryJun 24, 2026Inadequacy of Device Shape and/or Size

    TRAUMATIC INJURY WITH MASK REMOVAL. DURING SEVERAL USES OF THE MASK, THE PATIENT HAD INJURIES WITH BLEEDING WHEN THE MASK WAS REMOVED. ONE PATIENT HAD A CUT ON THE TONGUE FRENULUM AND A HEMATOMA, WHICH REQUIRED AN ENT CHECK. THE MASK WAS USED CORRECTLY BY TRAINED MEDICAL STAFF. THE ISSUE HAS BEEN REPORTED TO QUALITY FOR FOLLOW-UP AND ANALYSIS. PATIENT OUTCOME: UNKNOWN.

    Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available; Hematoma; Hemorrhage/Blood Loss/Bleeding

    MAUDE report 25612369 ↗
  • InjuryJun 24, 2026Inadequacy of Device Shape and/or Size

    TRAUMATIC INJURY WITH MASK REMOVAL. DURING SEVERAL USES OF THE MASK, THE PATIENT HAD INJURIES WITH BLEEDING WHEN THE MASK WAS REMOVED. ONE PATIENT HAD A CUT ON THE TONGUE FRENULUM AND A HEMATOMA, WHICH REQUIRED AN ENT CHECK. THE MASK WAS USED CORRECTLY BY TRAINED MEDICAL STAFF. THE ISSUE HAS BEEN REPORTED TO QUALITY FOR FOLLOW-UP AND ANALYSIS. PATIENT OUTCOME: UNKNOWN.

    Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available; Hematoma; Hemorrhage/Blood Loss/Bleeding

    MAUDE report 25604313 ↗
  • InjuryJul 10, 2025Device Appears to Trigger Rejection; Device Appears to Trigger Rejection

    THE CUSTOMER REPORTED THAT PATIENT HAD SENSORY DEFICIT OF THE TIP OF THE TONGUE AFTER GA EXAM. THE DEFICIT WAS STILL PERSISTING 7 DAYS AFTER THE PROCEDURE.

    Patient problems: Hyporesponsive to stimuli; Nerve Damage

    MAUDE report 22472588 ↗
  • InjuryJul 10, 2025Device Appears to Trigger Rejection; Device Appears to Trigger Rejection

    THE CUSTOMER REPORTED THAT PATIENT HAD SENSORY DEFICIT OF THE TIP OF THE TONGUE AFTER GENERAL ANESTHESIA (GA) EXAM. THE DEFICIT WAS STILL PERSISTING 7 DAYS AFTER THE PROCEDURE.

    Patient problems: Hyporesponsive to stimuli; Nerve Damage

    MAUDE report 22466848 ↗

Other AIRWAY, OROPHARYNGEAL, ANESTHESIOLOGY devices

All AIRWAY, OROPHARYNGEAL, ANESTHESIOLOGY devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.